Listen to this episode on:
In this episode of Power to the Patients, Dan Karlin, Chief Medical Officer at MindMed, talks about the potential of psychedelic therapies, especially LSD, to help treat anxiety. He shares his personal journey through psychiatry and addiction medicine, and how their research is aiming to expand the tools available for treating anxiety disorders.
Key topics include:
- Treatment limitations: Dr. Karlin shares his thoughts on the limitations of traditional treatments like SSRIs.
- Breakthroughs: Exploring the hope that psychedelics might offer by shifting treatment paradigms.
- LSD and anxiety disorders: Dr. Karlin explains MindMed’s research on how LSD works and how it could impact generalized anxiety disorder (GAD)
- Psychedelic-assisted therapy: Dan discusses the importance of therapy alongside these treatments.
Join us for an insightful conversation exploring how MindMed is leading the way in developing new solutions for mental health, and how this could change the way we treat anxiety.
Related Podcasts
Subscribe to Power's Newsletter
Stay ahead with a new patient recruitment insight every week.